Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 126

Related Citations for PubMed (Select 9550245)

1.

A naturalistic study of clinical use of risperidone.

Binder RL, McNiel DE, Sandberg DA.

Psychiatr Serv. 1998 Apr;49(4):524-6.

PMID:
9550245
2.

Antipsychotic treatment in child and adolescent first-episode psychosis: a longitudinal naturalistic approach.

Castro-Fornieles J, Parellada M, Soutullo CA, Baeza I, Gonzalez-Pinto A, Graell M, Paya B, Moreno D, de la Serna E, Arango C.

J Child Adolesc Psychopharmacol. 2008 Aug;18(4):327-36. doi: 10.1089/cap.2007.0138.

PMID:
18759642
3.

[Long-acting injectable risperidone: naturalistic study in three hospitals in Aquitaine].

Raignoux C, Dusouchet T, Bret P, Queuille E, Biscay ML, Caron J, Bret MC.

Encephale. 2007 Dec;33(6):973-81. doi: 10.1016/j.encep.2006.07.003. Epub 2007 Sep 4. French.

PMID:
18789790
4.

[Prescription practices of antipsychotic medication in early psychosis: a two-year follow-up survey of subjects admitted in two psychiatric hospitals of South-Western France].

Grolleau A, Cougnard A, Parrot M, Kalmi E, Desage A, Misdrahi D, Brun-Rousseau H, Verdoux H.

Encephale. 2007 May-Jun;33(3 Pt 1):326-31. French.

PMID:
17675930
6.

Risperidone use in a teaching hospital during its first year after market approval: economic and clinical implications.

Carter CS, Mulsant BH, Sweet RA, Maxwell RA, Coley K, Ganguli R, Branch R.

Psychopharmacol Bull. 1995;31(4):719-25.

PMID:
8851645
7.

Comparison of risperidone and olanzapine as used under "real-world" conditions in a state psychiatric hospital.

Advokat C, Dixon D, Schneider J, Comaty JE Jr.

Prog Neuropsychopharmacol Biol Psychiatry. 2004 May;28(3):487-95.

PMID:
15093956
8.

A naturalistic outcome study of risperidone treatment among hospital patients.

Negrón AE, Leiderman EA, Parkadavil M, Cienfuegos A, Javitt DC.

Psychiatr Serv. 1996 Oct;47(10):1118-20.

PMID:
8890343
9.

Effectiveness of antipsychotic therapy in a naturalistic setting: a comparison between risperidone, perphenazine, and haloperidol.

Coley KC, Carter CS, DaPos SV, Maxwell R, Wilson JW, Branch RA.

J Clin Psychiatry. 1999 Dec;60(12):850-6.

PMID:
10665632
10.

Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.

Emsley R, Oosthuizen P, Koen L, Niehaus DJ, Medori R, Rabinowitz J.

Clin Ther. 2008 Dec;30(12):2378-86. doi: 10.1016/j.clinthera.2008.12.020.

PMID:
19167596
11.

Efficacy of risperidone versus olanzapine in patients with schizophrenia previously on chronic conventional antipsychotic therapy: a switch study.

Wang X, Savage R, Borisov A, Rosenberg J, Woolwine B, Tucker M, May R, Feldman J, Nemeroff CB, Miller AH.

J Psychiatr Res. 2006 Oct;40(7):669-76. Epub 2006 Jun 9.

PMID:
16762371
12.

Early clinical experience with risperidone long-acting injection: a prospective, 6-month follow-up of 100 patients.

Taylor DM, Young CL, Mace S, Patel MX.

J Clin Psychiatry. 2004 Aug;65(8):1076-83.

PMID:
15323592
13.

Risperidone use at a state hospital: a clinical audit 2 years after the first wave of risperidone prescriptions.

Chengappa KN, Sheth S, Brar JS, Parepally H, Marcus S, Gopalani A, Palmer A, Baker RW, Schooler NR.

J Clin Psychiatry. 1999 Jun;60(6):373-8.

PMID:
10401915
14.

Risperidone and olanzapine in adults with intellectual disability: a clinical naturalistic study.

Bokszanska A, Martin G, Vanstraelen M, Holt G, Bouras N, Taylor D.

Int Clin Psychopharmacol. 2003 Sep;18(5):285-91.

PMID:
12920389
15.

Risperidone compared with olanzapine in a naturalistic clinical study: a cost analysis.

Taylor DM, Wright T, Libretto SE; Risperidone Olanzapine Drug Outcomes Studies in Schizophrenia (RODOS) U.K. Investigator Group.

J Clin Psychiatry. 2003 May;64(5):589-97.

PMID:
12755664
16.

A long-term, multicenter, open-label study of risperidone in elderly patients with psychosis. On behalf of the Risperidone Working Group.

Davidson M, Harvey PD, Vervarcke J, Gagiano CA, De Hooge JD, Bray G, Dose M, Barak Y, Haushofer M.

Int J Geriatr Psychiatry. 2000 Jun;15(6):506-14.

PMID:
10861916
17.
18.
19.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
20.

[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].

Llorca PM, Miadi-Fargier H, Lançon C, Jasso Mosqueda G, Casadebaig F, Philippe A, Guillon P, Mehnert A, Omnès LF, Chicoye A, Durand-Zaleski I.

Encephale. 2005 Mar-Apr;31(2):235-46. Review. French.

PMID:
15959450
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk